Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Tuesday's After-Market Session

Author: Benzinga Insights | June 18, 2024 03:31pm

Gainers

  • Nexalin Technology (NASDAQ:NXL) shares rose 55.8% to $1.62 during Tuesday's after-market session. The market value of their outstanding shares is at $12.0 million.
  • Dynatronics (NASDAQ:DYNT) stock rose 14.74% to $0.4. The company's market cap stands at $2.1 million.
  • Oncology Institute (NASDAQ:TOI) shares moved upwards by 10.8% to $0.45. The market value of their outstanding shares is at $33.5 million.
  • SAB Biotherapeutics (NASDAQ:SABS) stock rose 8.94% to $2.8. The market value of their outstanding shares is at $25.8 million.
  • Bone Biologics (NASDAQ:BBLG) shares moved upwards by 8.04% to $1.61. The company's market cap stands at $1.7 million.
  • Virpax Pharmaceuticals (NASDAQ:VRPX) shares increased by 7.17% to $0.61. The market value of their outstanding shares is at $1.6 million.

Losers

  • Biolase (NASDAQ:BIOL) stock fell 9.9% to $0.12 during Tuesday's after-market session. The company's market cap stands at $3.8 million.
  • Evaxion Biotech (NASDAQ:EVAX) stock declined by 9.53% to $2.47. The market value of their outstanding shares is at $13.3 million.
  • Soligenix (NASDAQ:SNGX) stock decreased by 8.5% to $3.88. The market value of their outstanding shares is at $3.8 million.
  • Redhill Biopharma (NASDAQ:RDHL) stock decreased by 8.19% to $0.36. The company's market cap stands at $11.4 million.
  • Sunshine Biopharma (NASDAQ:SBFM) stock decreased by 7.86% to $0.36. The company's market cap stands at $6.8 million.
  • Ensysce Biosciences (NASDAQ:ENSC) shares fell 7.82% to $0.52. The company's market cap stands at $3.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BBLG BIOL DYNT ENSC EVAX NXL RDHL SABS SBFM SNGX TOI VRPX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist